Monday, March 20, 2023

Comments by FiddamanBlog

Showing 6 of 6 comments.

  • Thanks Fiachra.

    Isn’t it ironic that warning people about the nasty side of these drugs has become a possible life-saving action, when all we seem to hear is the “drugs save lives.”

    I’ve never been one to follow that mantra. I’ve seen and wrote about many people who would probably still be alive today if they had not been prescribed these types of meds.

    I wish this craziness would just stop. I wish Dr’s would wake up and take what their patients have to say as the truth. I wish we had a regulator in place that could show some backbone too.

    Sadly, none of the above will ever be achieved if we just shrug our shoulders at this problem. I guess we all have a duty to keep banging the drum.

  • Thank you Krissy.

    Natalie was a stunningly beautiful young woman of such great intelligence. When I first read your online account on David Healy’s blog I, as you know, commended your writing skills.

    As fate would have it we met and, the rest is history, as they say.

    You’ve been a shining light for me and your courage in the face of adversity serves as a constant reminder to us all that we each, individually, have a part to play in protecting future generations.

    I’m happy we met.
    I’m happy we continue down this road together.

    Much love.

  • It was a pleasure to talk about the advocacy work I do. Since its launch on Mad in America, I’ve received many emails requesting for opportunities to write guest posts on my blog. I will answer them all soon.

    In the meantime, can I just reiterate that I accept personal accounts, in the main, about withdrawal effects from SSRIs and SSRI related suicides.

    Obviously, I take these personal accounts at face value and on good faith.

    I think it’s important that people write about their experiences and, hopefully, offering a platform to allow this will help people find a small grain of peace in their lives and also warn others who are contemplating the use of SSRIs.

    Once again, thank you to James and the Mad in America team for allowing me to ‘vent’ via these brilliant series of podcasts.

    Bob Fiddaman

  • “Researchers contend that the harmful costs of taking antidepressants outweigh any potential benefits.”

    Exactly what are the benefits?

    Every single label for SSRIs show us the potential harms, ie; ‘side effects’.

    I’ve not come across one single patient information leaflet that actually lists the benefits, it’s also a question I have put to the UK medicines regulator, the MHRA, on countless occasions. To date, not one single person from any global drug regulatory agency has been able to tell me of the benefits of SSRIs.

    If SSRIs save lives then the label doesn’t suggest that they do. If SSRIs cure depression or other related “disorders”, the label doesn’t tell us so.

    So, without sounding like a stuck record, exactly what are the benefits? There’s plenty of professionals on Mad In America, can any answer this rather simple question?

  • To date, not one single person from any global drug regulatory agency has been able to tell me of the benefits of SSRIs. The same question should be asked of antipsychotics. As advocates we have, for many years now, focused on the risks of these types of meds, and rightly so. We seemed to have overlooked what is staring us in the face – ergo, what are the benefits of these drugs?

    11 years corresponding with the British drug regulator, the MHRA, and they still cannot provide me with one single benefit of SSRIs, kind of absurd given that drugs are granted a licence based on the benefit/risk ratio.

  • Jim,

    Thanks for highlighting the work I did on this. For the first two weeks I was at the trial – quite an unbelievable experience. Glaxo’s attorney’s were actually like the way I described them in my blog posts. Repetitive and boring being just two words I would use to describe them.

    It was an important case. The 22 deaths knowledge had been previously sealed away from the public – Unbeknown to me this was information that the British regulator (MHRA) have had for a long time. Despite knowing that 80% of the suicides in Paxil clinical trials happened to consumers who were all over the age of 30, the MHRA and, more than likely, the FDA, highlighted the fact that Paxil wasn’t safe for kids.

    Here’s the rub. There were no completed suicides in Paxil pediatric trials.

    It’s up to the people to do the math on this one.

    Here’s some recent correspondence with the MHRA regarding this issue.

    Thanks again, not only for highlighting my input into the Dolin Vs. GSK case but also for your own advocacy work.

    Bob Fiddaman